Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed information about a clinical trial involving CIMAvax and nivolumab for treating advanced lung and head and neck cancers, while adding new cancer types and registry identifiers.SummaryDifference54%
- Check43 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.SummaryDifference0.2%
- Check50 days agoChange DetectedThe page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 28, 2025, to March 25, 2025.SummaryDifference0.2%
- Check79 days agoChange DetectedThe webpage has undergone significant changes, including the removal of multiple principal investigators and their contact information, as well as updates to the last update posted date and interim analysis details.SummaryDifference2%
- Check86 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.